Catherine Ramsey
Stock Analyst at Baird
(2.79)
# 1,852
Out of 4,931 analysts
51
Total ratings
31.58%
Success rate
3.04%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Catherine Ramsey
Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
---|---|---|---|---|---|---|---|
ILMN Illumina | Maintains: Neutral | $84 → $105 | $95.50 | +9.95% | 6 | Jul 28, 2025 | |
WAT Waters | Maintains: Outperform | $374 → $352 | $278.00 | +26.62% | 11 | Jul 16, 2025 | |
TWST Twist Bioscience | Maintains: Outperform | $54 → $44 | $25.00 | +76.00% | 7 | May 6, 2025 | |
RVTY Revvity | Maintains: Outperform | $127 → $125 | $86.46 | +44.58% | 5 | Apr 29, 2025 | |
NTRA Natera | Maintains: Outperform | $183 → $188 | $141.08 | +33.26% | 6 | Feb 28, 2025 | |
CSTL Castle Biosciences | Maintains: Outperform | $36 → $37 | $19.65 | +88.30% | 8 | Feb 28, 2025 | |
TMO Thermo Fisher Scientific | Maintains: Outperform | $695 → $665 | $454.74 | +46.24% | 2 | Nov 1, 2022 | |
A Agilent Technologies | Maintains: Outperform | $155 → $160 | $113.98 | +40.38% | 5 | Aug 17, 2022 | |
EXAS Exact Sciences | Maintains: Outperform | $90 → $75 | $43.16 | +73.77% | 1 | Aug 3, 2022 |
Illumina
Jul 28, 2025
Maintains: Neutral
Price Target: $84 → $105
Current: $95.50
Upside: +9.95%
Waters
Jul 16, 2025
Maintains: Outperform
Price Target: $374 → $352
Current: $278.00
Upside: +26.62%
Twist Bioscience
May 6, 2025
Maintains: Outperform
Price Target: $54 → $44
Current: $25.00
Upside: +76.00%
Revvity
Apr 29, 2025
Maintains: Outperform
Price Target: $127 → $125
Current: $86.46
Upside: +44.58%
Natera
Feb 28, 2025
Maintains: Outperform
Price Target: $183 → $188
Current: $141.08
Upside: +33.26%
Castle Biosciences
Feb 28, 2025
Maintains: Outperform
Price Target: $36 → $37
Current: $19.65
Upside: +88.30%
Thermo Fisher Scientific
Nov 1, 2022
Maintains: Outperform
Price Target: $695 → $665
Current: $454.74
Upside: +46.24%
Agilent Technologies
Aug 17, 2022
Maintains: Outperform
Price Target: $155 → $160
Current: $113.98
Upside: +40.38%
Exact Sciences
Aug 3, 2022
Maintains: Outperform
Price Target: $90 → $75
Current: $43.16
Upside: +73.77%